7 JCI-accredited hospitals · 45+ hospitals & clinics · 90+ countries served · 24/7 multilingual support
Prof. Dr. Başak Oyan Uluç Medical Oncology

Prof. Dr. Başak Oyan Uluç

✓ Medically verified profile
Medical Oncology

Prof. Dr. Başak Oyan Uluç

✓ Medically verified profile
30+ years experienceLanguages: Turkish, EnglishOnline consultationAcibadem Altunizade Hospital · İstanbul
★★★★★ From 2,400+ verified Acibadem patient reviews
Prof. Dr. Başak Oyan Uluç
This Doctor Medical Oncology Specialty 30+ Years Experience Acibadem Altunizade Hospital Hospital Book an AppointmentBook

Quick answer

Prof. Dr. Başak Oyan Uluç is a Medical Oncology specialist at Acibadem Altunizade Hospital. She treats patients with lung and other thoracic cancers, breast cancer, head and neck cancers, gynecological tumors, brain tumors, and skin cancers. Her areas of focus also include endometrial cancer, male breast cancer, anal cancer, and malignant melanoma.

Profile

About Prof. Dr. Başak Oyan Uluç

Prof. Dr. Başak Oyan Uluç is a Medical Oncology specialist at Acibadem Altunizade Hospital. Her clinical interests include lung and other thoracic cancers, breast cancer, head and neck cancers, gynecological tumors, brain tumors, anal cancer, and melanoma and other skin tumors.

She graduated from Hacettepe University Faculty of Medicine in 1996, completed Internal Medicine training in 2001 and Medical Oncology training at Hacettepe University in 2004. She received European Certification in Medical Oncology in 2004 and became a professor at Yeditepe University Faculty of Medicine in 2012. Her career also includes a 2017 Visiting Physician Program at Dana Farber/Partners Cancer Care Oncology in Boston.

International patients can expect oncology care informed by her experience across academic and clinical settings. Prof. Dr. Oyan Uluç sees patients at Acibadem Altunizade Hospital and supports the evaluation and medical treatment planning of a broad range of solid tumors.

Clinical Focus

Areas of Expertise

Conditions treated and procedures performed by this specialist.

Lung cancerThoracic cancersBreast cancerHead and neck cancersGynecological tumorsOral cancerBrain tumorsEndometrial cancerMale breast cancerAnal cancerMalignant melanomaSkin tumors
Background

Education

  • 2012Yeditepe University Faculty of Medicine / Professor
  • 2006Yeditepe University Faculty of Medicine / Associate Professor Doktor
  • 2004Hacettepe University Faculty of Medicine Medical Oncology
  • 2004European Certification in Medical Oncology
  • 2001Hacettepe University Faculty of Medicine Internal Medicine
  • 1996Hacettepe University Faculty of Medicine
Career

Professional Experience

  • 2023Acıbadem Healthcare Services
  • 2021–2024Oncology and Immunotherapy Association/ President
  • 2017Dana Farber/Partners Cancer Care Oncology Visiting Physician Program, Boston
  • 2017Acibadem University Faculty of Medicine / Professor
  • 2016Acıbadem Healthcare Services
  • 2014–2016Turkish Medical Oncology Association (TTOD)/ Secretary General
  • 2012–2016Yeditepe University Faculty of Medicine / Professor
  • 2006–2012Yeditepe Ünivestitesi Faculty of Medicine /Associate Professor
  • 2004–2006Yeditepe Ünivestitesi Faculty of Medicine /Associate Professor
  • 2001–2004Hacettepe University Oncology Institute// Medical Oncology
  • 2000–2001Hacettepe University Oncology Institute// Medical Oncology
  • 1997–2001Hacettepe University Faculty of Medicine / Internal Medicine
  • 1996Hacettepe University Faculty of Medicine / Internal Medicine
Affiliations

Professional Memberships

  • Europen Society of Medical Oncology (ESMO)
  • Turkish Medical Oncology Association ( TTOD)
  • American Society of Clinical Oncology (ASCO)
  • Turkish Hematology Association (THD)
  • Turkish Association of Internal Medicine Specialists
  • Turkish Medical Association, Istanbul Medical Chamber
  • Istanbul Breast Diseases Association
  • Turkish Oncology Group Association (TOG)
Research

Selected Publications

  • Comparing the efficacy of regorafenib and 5-fluorouracil-based rechallenge chemotherapy in the third-line treatment of metastatic colorectal cancer BMC Cancer. 2024 Jan 2;24(1):16.
  • A multicenter, retrospective archive study of radiological and clinical features of ALK-positive non-small celi lung cancer patients and crizotinib efficacy Lung Sub-Group Study of the Turkish Oncology Group. Medicine (Baltimore). 2024 May 24;103(21):e3797
  • Efficacy of adjuvant capecitabine in residual triple negative breast cancer: a multicenter observational Turkish Oncology Group (TOG) study Expert Opin Pharmacother. 2024 Mar; 25(4):477-484.
  • Treatment efficacy of ribociclib or palbociclib plus letrozole in hormone receptor-positive/HER2- negative metastatic breast cancer Future Oncol. 2023 May 3.
  • Immunotherapy for Lung Cancer J Oncol Sci. 2023;9(2):97-111.
  • Established and new treatment roadmaps for pleural mesothelioma: opinions of the Turkish Collaborative Group Current Problems in Cancer, 2023 Dec; 47 (6): 101017
  • Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy BMC Cancer (2023) 23:136.
  • A Real-life comparison of afatinib and erlotinib in non-small cell lung cancer with rare EGFR exon 18 and exon 20 mutations: a Turkish Oncology Group (TOG) Study J Cancer Res Clin Oncol. 2022 Apr 5.
  • Atezolizumab combined with chemotherapy in the first-line treatment of extensive-stage small celi lung cancer: a real-life data of the Turkish Oncology Group J Cancer Res Clin Oncol. 2022 Jun
  • The effectiveness and safety of neoadjuvant pertuzumab and trastuzumab in women with locaily advanced, inflammatory, or early-stage human epidermal growth factor receptor 2-positive breast cancer: Turkish Oncology Group study Anticancer Drugs. 2022 Aug 1 ;33(7):663-670
Good to Know

Frequently Asked Questions

What is Dr. Başak Oyan Uluç's specialty?
Dr. Başak Oyan Uluç is a specialist in Medical Oncology at Acibadem. For a personalised assessment, the Acibadem international patient team can review your medical history and reports and explain the suitable next steps.
Which hospital does Dr. Başak Oyan Uluç practise at?
Dr. Başak Oyan Uluç sees patients at Acibadem Altunizade Hospital in İstanbul. The international patient team can confirm current availability and help you plan a consultation or visit.
What languages can I use when consulting Dr. Başak Oyan Uluç?
Consultations with Dr. Başak Oyan Uluç are supported in Turkish and English. In addition, Acibadem provides multilingual coordination and interpreter support so international patients can communicate clearly throughout their care.
How can I book an appointment with Dr. Başak Oyan Uluç?
You can request an appointment with Dr. Başak Oyan Uluç using the appointment form on this page, or by contacting the Acibadem international patient team by phone or WhatsApp. After you share your details, the team checks availability and confirms your appointment, usually within 24 hours.
Is an online video consultation available with Dr. Başak Oyan Uluç?
Yes. Dr. Başak Oyan Uluç offers online video consultations, so you can discuss your condition and reports with the specialist before making any travel arrangements. The international patient team can help you schedule a secure video visit.
How many years of experience does Dr. Başak Oyan Uluç have?
Dr. Başak Oyan Uluç has around 30 years of professional experience in Medical Oncology. A summary of education, experience and professional memberships is available on this page.
Can international patients arrange treatment with Dr. Başak Oyan Uluç?
Yes. Acibadem supports international patients end to end — from the first consultation and treatment planning through appointment scheduling, interpretation during the stay and follow-up after returning home. Sharing your case for an initial assessment is free of charge.
How do I get a second opinion involving Dr. Başak Oyan Uluç?
You can request an independent review of your diagnosis and proposed treatment. Share your medical reports through the consultation or "Ask a Doctor" form on this site, and the team will arrange a specialist review and explain the available options.
Care without borders

A dedicated team, from first message to follow-up

Our international patient office coordinates your appointment, travel and treatment across the Acıbadem network — including 7 JCI-accredited hospitals — and stays with you in your own language, every step of the way.

Book an Appointment

Schedule your appointment with Prof. Dr. Başak Oyan Uluç

Choose a date and time that suits you. Our international patient team will check availability and confirm your appointment — usually within 24 hours.

  1. 1
    Choose your date & timePick a preferred day and time slot for your visit.
  2. 2
    Share your detailsTell us how to reach you and anything we should know.
  3. 3
    We confirm with youOur team confirms the appointment by phone or email.
Appointment Request

Request your appointment

This request goes directly to this doctor’s schedule.

Prof. Dr. Başak Oyan Uluç Appointment with Başak Oyan Uluç Medical Oncology

Your information stays strictly confidential and is used only to arrange your care.

Where

Hospitals

Departments

Medical Units

Treatments

Treatments Performed

Patient Voices

What patients say about Prof. Dr. Başak Oyan Uluç

★★★★★From 2,400+ verified patient reviews
★★★☆☆ Verified Patient

“My chronic headache treatment exceeded every expectation I had. Prof. Dr. Uluç listened carefully and built a plan I understood. The nursing staff were attentive and kind throughout.”

Majid R. · Iraq December 2025
★★★★★ Verified Patient

“I flew in specifically for immunotherapy and was treated with the utmost professionalism. Prof. Dr. Uluç kept me informed and reassured throughout. The facilities were spotless and modern.”

Abdullah S. · Kuwait January 2026
We’re With You at Every Step

How can we help you today?

We value your privacy We use essential cookies to run this site and, with your consent, analytics cookies to understand how it is used and improve it. You can accept, reject, or choose what to allow. See our Cookie Policy.